BevNET Exclusive: SōRSE “Canna-Bus” Takes Processor on the Road

“We’re just trying to offer the opportunity to make products with a top of the line water-soluble format and to be able to wholesale our emulsion to other clients in your state.” – Zach Hershberger, SōRSE’s Operations Manager.

Learn more about SōRSE’s mobile unit – how it’s a new way for SōRSE to work with our partners at a time when CBD and cannabis co-packers are unevenly distributed and regulated across the country.

Read the full article.

 

SōRSE Debuts Water-Soluble 7.5% CBD Emulsion for Personal Care Products

personal care items

SEATTLE–SōRSE Technology, the leading water-soluble emulsion technology designed for infusing functional ingredients into consumer goods, announces the addition of 7.5% CBD liquid emulsion for personal care products to their product suite. SōRSE is designed for product developers to make oil-based functional ingredients water-soluble and more efficacious, while also providing the consumer with a consistent, safe experience. 

SōRSE, which currently powers over 60 infused products on the market, developed the 7.5% CBD emulsion for the personal care category to eliminate the current market’s sticky and unstable formulations. Personal care products offer a delivery method consumers are comfortable with and purchase frequently; consumers also expect an enjoyable and consistent experience just as they do with beverages and food items. SōRSE’s 7.5% water-soluble CBD emulsion seamlessly integrates, complements other ingredients, and can be modified for multiple SKUs.  

“While we are a functional ingredient supplier, our foundation is in water-soluble emulsion technology and product development,” commented CEO Howard Lee. “It’s through our technology that we’re changing how the personal care industry works with tricky functional ingredients like CBD that consumers demand. We’ve made working with our technology and ingredients simple so that we can focus on helping our partners deliver more enjoyable, more effective products.”  

SōRSE Technology is hosting a webinar on Thursday, February 25th on the benefits of water-soluble emulsion technology for personal care products to educate product developers on their new 7.5% CBD emulsion solution. Those interested in attending can register here or contact SōRSE directly at events@sorsetech.com for more information. 

About SōRSE Technology 

SōRSE Technology is the leading water-soluble emulsion technology designed for infusing functional ingredients into beverages, food items, personal care products, and medical applications. SōRSE is designed for product developers to make oil-based functional ingredients water-soluble and more efficacious, while also providing the consumer with a consistent, safe, and enjoyable experience. With over 200 years’ experience in food & beverage and an R&D team of 30+ employees, SōRSE is a partner that can take a producer from concept to commercialization quickly and efficiently. 

WSPA: Dry January Beverage Ideas

kleer powered by sorse

Participating in Dry January? WSPA-TV News Channel 7 based in South Carolina, recently featured a segment on Dry January Beverage Ideas and highlights SōRSE and describes some of our partners’, Aprch™ Beverage Co. , Kleer Sparkling Water and Mad Tasty as hydrating and restorative alternatives.

Watch the full segment here.

Tasting Panel Magazine: Taking the Waters

Mad Tasty Powered by SoRSE

An article in The Tasting Panel Magazine highlighted SōRSE and its partners Aprch™ Beverage Co. , Kleer Sparkling Water and MAD TASTY, commenting, “SōRSE’s success in developing emulsions and flavor profiles that make it convenient for manufacturers to incorporate broad-spectrum #CBD is paving the way for more functional products across a variety of categories.”

SoRSE in Tasting Panel

Read the full article on page 90 in the latest issue of Tasting Panel Magazine.

 

2020: A Year of Innovation & Expansion at SōRSE Technology

2020: A YEAR OF INNOVATION & EXPANSION FOR SORSE

2020 – what a year it has been! At the beginning of the year, the SōRSE team was busy working with our clients who were in the process of developing and launching products and preparing for live events. Then came March, and with it, Covid. Our work world changed, with many employees working remotely. Because SōRSE was deemed an essential business, emulsion production continued, as did the support of our clients. Instead of attending conventions and trade shows, we pivoted to hosting and attending virtual events and offering educational webinars to connect and engage with our partners and community.

 

2020 has been challenging for many reasons, but at SōRSE, there is much to celebrate – including over 1 billion unique views of the articles in which we’ve been featured. Here are some of the highlights from 2020.   

Mary Wagner and Allen Hsieh Join the Board of Directors 

In JanuaryMary Wagner and Allen Hsieh were appointed to the SōRSE Board of DirectorsMary Wagner is a recognized executive leader with a reputable career in the food industry, having created innovative products and developed measures to ensure food quality and safety. Allen Hsieh has over 25 years of experience in business and finance and has managed companies that have generated between $100 million and $500 million in revenue annually.   

OneRepublic’s Ryan Tedder Shares the Story Behind Mad Tasty with Forbes 

In February, Forbes published an interview with Ryan Tedder in which he explains why he decided to start a CBD beverage company, how he discovered SōRSE, and how SōRSE provided the best possible solution for creating his successful beverage line, Mad Tasty 

SōRSE Featured in Bon Appetit’s “How to Find a CBD Product That Works” 

At SōRSE, one of our goals is to educate consumers on the benefits of products that utilize water-soluble emulsion technology. In March, we were able to share our knowledge on “How to Find a CBD Product That Works with Bon Appétit magazine. In the articlewe discuss important topics such as dosing, bioavailability, the differences between different types of CBD products, COAs, and how to figure out if a product is utilizing water-soluble technology. 

First Beverages in Canadian Marketplace Are Powered by SōRSE 

In AprilBenzinga broke the news that the first beverages to reach the Canada’s Cannabis 2.0 market had hit the shelves, and even better, they were powered by SōRSE! Our partner, The Valens Company, collaborated with A1 Cannabis Company to create Summit, a THC Citrus Water, and Basecamp, a CBD Iced Tea. We were proud to see our technology play a part in bringing these drinks to Canadian shelves.  

SōRSE Secures #61 on Fast Co’s Best Workplaces for Innovators List 

In the beginning of AugustSōRSE Technology was included in Fast Co’s Best Workplaces for Innovators list for 2020Nearly 900 companies applied to be recognized by Fast Companyand SōRSE earned position #61 while also being the only cannabis adjacent company included on the list. Fast Company is an influential, cutting-edge magazine focused on “the future of business” with over 16 million monthly unique visitors.  

SōRSE Partners with Pascal Biosciences on Cancer Research 

In SeptemberSōRSE announced that it was entering into a collaborative research agreement with Pascal Biosciences, advancing Pascal’s PAS-393 into clinical testing. Pascal and SōRSE would share their respective technologies to test the cannabinoid PAS-393 in human volunteers; this will enable testing of cancer patients treated with checkpoint inhibitors.  

Donna Wamsley Shares Her Insights on Flavor Trends with Forbes 

Donna Wamsley is not only our Director of Research and Analytics who works on emulsion innovationshe is also a trained flavorist, bringing a depth of knowledge on flavor and creating flavor profiles to her work. In October, Forbes published an interview with Donna in which she discusses her work at SōRSEthe process of becoming a flavorist, and flavor trends she sees emerging in 2021.   

SōRSE Hosts the First Annual SōRSE Summit 

To connect with our partners and share our knowledge with them, SōRSE hosted its first annual, virtual summit in October, featuring presentations for our 50+ clients on a variety of topics on the infused food and beverage marketTopics included: Trends in FlavorEmulsion Customization, Maturation of the Cannabis and CBD Marketplace, amongst many others. 

SōRSE Launches Clear CBD Emulsion 

Near the end of November, we announced the creation of SōRSE Clear, a stable, clear emulsion with a minimal sensory profile. The product made its official debut at our inaugural SōRSE Summit, which was a big win for our Science team and will be a game changer for our customers in the infused beverage space.  

SōRSE Expands into Latin America through Joint Venture with FCM Global 

In November, SōRSE ventured into the Latin American marketplace by announcing a joint venture with FCM Global, based in Medellin, Colombia, which produces organic hemp and cannabis oils. By entering this partnership with FCM, SōRSE is now  licensed to apply its technology to THC, CBD, and other cannabinoids in ColombiaThe emulsion will be branded as “SōRSE by FCM GLOBAL.” 

SōRSE and Pascal Validate and Optimize Cannabinoid Delivery for Cancer Treatment 

Three months after announcing the collaborative research agreementSōRSE and Pascal Biosciences shared the news that they will be moving forward with clinical trials of the cannabinoid PS-393 in 2021 for cancer patients treated with checkpoint inhibitors. This will mark the first pharmaceutical use of SōRSE’s formulation technology in concert with Pascal’s intellectual property.  

Emily Skrobecki Shares Her Experience Working at SōRSE During the Age of Covid with The Business Journals’ Bizwomen 

At the beginning of December, Bizwomen published an essay written by our Process Engineering Manager, Emily Skrobeckiin which she explained how she prioritizes aspects of her job and communicates with her team while working remotely. Emily’s piece illustrates how SōRSE employees are committed to contributing to the company’s success and can adjust the way they work to fit any difficult situation 

 

If you’re interested in learning more about SōRSE and its accomplishments this year, download our Annual Report that summarizes the myriad ways we’ve innovated and expanded our product offerings, services, and production in 2020. We’ve learned a lot from the challenges we faced in 2020 and look forward to the promise and hope that 2021 brings. 

SōRSE & Pascal Optimize Cannabinoid Formulation for Development of Cancer Treatment

Pascal Biosciences and SōRSE Technology Optimize Cannabinoid Formulation for Clinical Development of Cancer Treatment

SEATTLE & VANCOUVER, British Columbia–Pascal Biosciences Inc. (TSX.V:PAS) (OTC:BIMUF) (“Pascal” or the “Company”) and SōRSE Technology Corporation (“SōRSE”) have validated and optimized a formula for oral cannabinoid delivery. Their shared efforts are advancing the cannabinoid PAS-393 towards clinical testing against cancer.

“This progress is very promising because this step is critical for testing in human volunteers,” said Pascal CEO Patrick Gray. “We will next identify a drug product manufacturer to prepare our product for testing in cancer patients treated with checkpoint inhibitors.”

It will be the first pharmaceutical use of the novel formulation technology developed by SōRSE and the first clinical trial for Pascal and SōRSE. This collaboration utilizes propriety discoveries by both companies, including Pascal’s intellectual property, which covers the use of cannabinoids in cancer patients treated with checkpoint inhibitors, and SōRSE’s proprietary formulation expertise.

“It’s great to see such rapid progress with the in vitro studies using our formulation technology,” said SōRSE CEO Howard Lee. “We are on track to enter our first clinical trial with Pascal within a year.”

Following characterization of safety and pharmacology in a Phase 1a clinical trial, Pascal and SōRSE may elect to continue clinical development as equal partners in a Phase 1b cancer trial in combination with a checkpoint inhibitor.

About Pascal Biosciences Inc.

Pascal is a biotechnology company targeting innovative therapies for serious diseases, including COVID-19. Pascal is also developing treatments for cancer with targeted therapies for acute lymphoblastic leukemia and cannabinoid-based therapeutics. Pascal’s leading portfolio also comprises a small molecule therapeutic, PAS-403, that is advancing into clinical trials for the treatment of glioblastoma, and PAS-393, an immuno-stimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy. For more information, visit www.pascalbiosciences.com.

About SōRSE Technology

SōRSE Technology Corporation is a water-soluble emulsion technology designed for product developers to provide consumers with a better, more consistent cannabinoid experience with greater bioavailability, near-perfect dosing, shelf-stability, and safe ingredients. Its patent-pending technology converts oil into SōRSE, a proprietary water-soluble emulsion, for infusing CBD and other functional ingredients into beverages, food items, topicals, and medical applications. SōRSE Technology currently powers more than 45 leading products in the CBD space. For more information, visit www.sorsetechnology.com.

Contacts

SōRSE Technology Press:
Jon Lindsay Phillips
RLM PR
SorseTech@rlmpr.com
+1-646-828-8566